US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
Dexxos Participacoes S.A (DEXP4) 銘柄情報

Dexxos Participacoes S.A (DEXP4)

7.05

0.05

(0.714286%)

終了 6月14日 5:55AM

Dexxos Participacoes S.A (DEXP4) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

7.05

( 0.71% )

買値

6.91

売値

7.06

出来高

53,100

6.92 日の範囲 7.05

6.87 52 週間の範囲 9.47

時価総額

前日終値

7.00

始値

6.92

時刻

最終取引時間

財務取引量

R$ 367,771

VWAP

6.93

平均取引量 (3 か月)

R$ 129,500

発行済株式数

120,513,257

配当利回り

(11.69%)

PER

5.93

1 株当たり利益 (EPS)

1.17

歳入

1.92B

純利益

142.4M

Dexxos Participações S.A. engages in the production and sale of thermosetting resins to the reconstituted wood panels industry in Brazil. The company operates through the Chemicals and Steel Tubes segments. It is also involved in the production of formaldehyde and hexamine; resale of methanol and ot... Dexxos Participações S.A. engages in the production and sale of thermosetting resins to the reconstituted wood panels industry in Brazil. The company operates through the Chemicals and Steel Tubes segments. It is also involved in the production of formaldehyde and hexamine; resale of methanol and other chemical products; and manufacture of steel tubes for the civil construction, infrastructure, automobile, petroleum, and gas markets. The company was formerly known as GPC Participações S.A. and changed its name to Dexxos Participações S.A. in June 2021. Dexxos Participações S.A. was founded in 1929 and is headquartered in Rio de Janeiro, Brazil. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.dexxos.com.br

本社

Rio De Janeiro, Brazil

設立

2026

Dexxos Participacoes S.A is listed in the sector of the ボベスパ (ブラジル) with ticker DEXP4. The last closing price for Dexxos Participacoes S.A PN was R$7. Over the last year, Dexxos Participacoes S.A PN shares have traded in a share price range of R$ 6.87 to R$ 9.47.

Dexxos Participacoes S.A PN currently has 120,513,257 shares in issue. The market capitalisation of Dexxos Participacoes S.A PN is R$849.62 million. Dexxos Participacoes S.A PN has a price to earnings ratio (PE ratio) of 5.93.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.06	0.858369098712	6.99	7.37	6.91	19525	6.94847631	PR
4	-0.12	-1.67364016736	7.17	7.37	6.91	8080	7.01062706	PR
12	-0.15	-2.08333333333	7.2	7.67	6.87	4896	7.13859477	PR
26	-2.04	-22.4422442244	9.09	9.47	6.87	5968	7.54561091	PR
52	-1.88	-21.0526315789	8.93	9.47	6.87	5086	7.89668298	PR
156	-2.68	-27.5436793422	9.73	13.45	6.87	5744	8.93760778	PR
260	-35.05	-83.2541567696	42.1	42.1	5.64	6461	8.9772355	PR

DEXP4 - Frequently Asked Questions (FAQ)

What is the current Dexxos Participacoes S.A share price?

The current share price of Dexxos Participacoes S.A is R$ 7.05

How many Dexxos Participacoes S.A shares are in issue?

Dexxos Participacoes S.A has 120,513,257 shares in issue

What is the market cap of Dexxos Participacoes S.A?

The market capitalisation of Dexxos Participacoes S.A is BRL 849.62M

What is the 1 year trading range for Dexxos Participacoes S.A share price?

Dexxos Participacoes S.A has traded in the range of R$ 6.87 to R$ 9.47 during the past year

What is the PE ratio of Dexxos Participacoes S.A?

The price to earnings ratio of Dexxos Participacoes S.A is 5.93

What is the cash to sales ratio of Dexxos Participacoes S.A?

The cash to sales ratio of Dexxos Participacoes S.A is 0.44

What is the registered address of Dexxos Participacoes S.A?

The registered address for Dexxos Participacoes S.A is Rua do Passeio, 70, Rio de Janeiro, Rio de Janeiro, 20021-290

What is the Dexxos Participacoes S.A website address?

The website address for Dexxos Participacoes S.A is www.dexxos.com.br

EZ2

11-12-22-24. 🙏

FlashySage44

FlashySage44 27分前

The day of reckoning is coming.
Two and a half weeks until the Next ER.
8 and a half until the August one.
No buyout in sight.
When will the longs start to question the buyout not happening?
I am very interested to see what this place will be saying come September

FlashySage44

FlashySage44 45分前

You’re not wolv?

jay_tee

jay_tee 1時間前

That “yup still there” has to be the most asinine post ever. Where else would worthless paper/digital em shares be? Sure the shares are there BUT Seamus has taken its value and poured it into FOXO. He played us all well at least up to this point….safe shares sitting at .000001 is toilet paper

doogdilinger

doogdilinger 1時間前

Right place at the right time BERK buddy:

joe_techi

joe_techi 1時間前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

xoom 1時間前

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 2時間前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 2時間前

Is july going to be IBATs Month?

rodeoup

rodeoup 2時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 3時間前

please send me the email

satter

satter 3時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 3時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 3時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 3時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 4時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 4時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 4時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 5時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 5時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 5時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 5時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

Dexxos Participacoes S.A PN

Solution Financial

NewDay Funding 2018-2

Sigma Fin.nts15

Latrobe Magnesium

2.75% 2028 Bond 2.75% 2028

HSBC MSCI Emerging Marke...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。